Best SR (2014a) Rapid relief of treatment resistant depression by facilitated ketamine infusion: a preliminary report. Act Nerv Super 56(1):28–36

Article  Google Scholar 

Best SRD (2014b) Combined ketamine/transcranial magnetic stimulation treatment of severe depression in bipolar I disorder. J ECT 30(4):e50–e51

Article  PubMed  Google Scholar 

Best SR (2015) Combined ketamine and transcranial magnetic stimulation for treatment resistant depression in the context of chronic OCD: a case report. Neuropsychiatr Electrophysiol 1(1):1–4

MathSciNet  Google Scholar 

Best SRD, Griffin B (2015) Combination therapy utilizing ketamine and transcranial magnetic stimulation for treatment-resistant depression: a case report. Int J Neurosci 125(3):232–234

Article  CAS  PubMed  Google Scholar 

Best S, Pavel DG (2017) Combined transcranial magnetic stimulation and ketamine for treatment of refractory mood disorder, anxiety, and pain: A case report. Curr Neurobiol 8(1):1–4

Google Scholar 

Best SR, Pavel DG, Haustrup N (2019) Combination therapy with transcranial magnetic stimulation and ketamine for treatment-resistant depression: a long-term retrospective review of clinical use. Heliyon 5(8):e02187

Article  PubMed  PubMed Central  Google Scholar 

Cavenaghi VB, Da Costa LP, Lacerda ALT, Hirata ES, Miguel EC, Fraguas R (2021) Subcutaneous ketamine in depression: a systematic review. Front Psych 12:513068

Article  Google Scholar 

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, … Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus 16(4):420–429

Corriger A, Pickering G (2019) Ketamine and depression: a narrative review. Drug Des Dev Ther 13:3051

Article  CAS  Google Scholar 

Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS (2013) A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatr 58(7):376–385

Article  Google Scholar 

Driessen E, Hollon SD, Bockting CL, Cuijpers P, Turner EH (2015) Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US National Institutes of Health-funded trials. PLoS ONE 10(9):e0137864

Article  PubMed  PubMed Central  Google Scholar 

Filipčić I, Filipčić IŠ, Milovac Ž, Sučić S, Gajšak T, Ivezić E, … Heilig M (2019) Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial. J Psychiatr Res 114:113–119

Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, ... Mathew SJ (2014) Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 17(2):331–336

Harvey PO, Van den Eynde F, Zangen A, Berlim MT (2015) Neural correlates of clinical improvement after deep transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a case report using functional magnetic resonance imaging. Neurocase 21(1):16–22

Article  PubMed  Google Scholar 

Howes OD, Thase ME, Pillinger T (2022) Treatment resistance in psychiatry: state of the art and new directions. Mol Psychiatry 27(1):58–72

Article  PubMed  Google Scholar 

Hui J, Tremblay S, Daskalakis ZJ (2019) The Current and future potential of transcranial magnetic stimulation with electroencephalography in psychiatry. Clin Pharmacol Ther 106(4):734–746

Article  PubMed  Google Scholar 

Kroenke K, Spitzer RL, Williams JB (2001) The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613

Lally N, Nugent AC, Luckenbaugh DA, Ameli R, Roiser JP, Zarate C (2014) Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Transl Psychiatry 4(10):e469–e469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, … Zangen A (2015) Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatr 14(1):64–73

Li W, Zhou Y, Liu W, Wang C, Lan X, Zhang Z, … Ning Y (2022) Long-term outcomes of repeated ketamine infusions in patients with unipolar and bipolar depression: A naturalistic follow-up study. J Affect Disord 300:172–178

Li H, Hou L, Wang D, Wu Q, Li H, He W, ... Cheng J (2023) Response rate and safety of antidepressants combined with electroconvulsive therapy in adolescent depression: real-world clinical application. J Affect Disord 339:98–103

Loo C, Glozier N, Barton D, Baune BT, Mills NT, Fitzgerald P, ... Rodgers A (2023) Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial. Br J Psychiatr 223(6):533–541

Ma S, Yang J, Yang B, Kang L, Wang P, Zhang N, Zong X, Wang Y, Liu Z (2021) The Patient Health Questionnaire-9 vs. the Hamilton Rating Scale for depression in assessing major depressive disorder. Front Psych 12:747139

Nikayin S, Murphy E, Krystal JH, Wilkinson ST (2022) Long-term safety of ketamine and esketamine in treatment of depression. Exp Opin Drug Saf 21(6):777–787

Pennybaker SJ, Niciu MJ, Luckenbaugh DA, Zarate CA (2017) Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. J Affect Disord 208:560–566

Article  CAS  PubMed  Google Scholar 

Redgrave J, Day D, Leung H, Laud PJ, Ali A, Lindert R, Majid A (2018) Safety and tolerability of transcutaneous vagus nerve stimulation in humans; a systematic review. Brain Stimul 11(6):1225–1238

Article  CAS  PubMed  Google Scholar 

Rong C, Park C, Rosenblat JD, Subramaniapillai M, Zuckerman H, Fus D, ... McIntyre RS (2018) Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder. Int J Environ Res Public Health 15(4):771

Rossi S, Antal A, Bestmann S, Bikson M, Brewer C, Brockmöller J, ... Hallett M (2021) Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clin Neurophysiol 132(1):269–306

Roth Y, Pell GS, Chistyakov AV, Sinai A, Zangen A, Zaaroor M (2014) Motor cortex activation by H-coil and figure-8 coil at different depths. Combined motor threshold and electric field distribution study. Clin Neurophysiol 125(2):336–343

Shanok NA, Rodriguez S, Muzac S, Del Pino CH, Brown L, Rodriguez R (2023) Deep transcranial magnetic stimulation alters resting-state neurophysiological traits in major depressive disorder. J Affect Disord 337:104–111

Article  PubMed  Google Scholar 

Suzuki A, Hara H, Kimura H (2022) Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant. Neuropharmacology 222:109308. https://doi.org/10.1016/j.neuropharm.2022.109308

Tateishi H, Mizoguchi Y, Monji A (2022) Is the therapeutic mechanism of repetitive transcranial magnetic stimulation in cognitive dysfunctions of depression related to the neuroinflammatory processes in depression?. Front Psych 13:834425

Tendler A, Harmelech T, Gersner R, Roth Y (2021) Seizures provoked by H-coils from 2010 to 2020. Brain Stimul 14(1):66–68

Article  PubMed  Google Scholar 

Tendler A, Goerigk S, Zibman S, Ouaknine S, Harmelech T, Pell GS, ... Roth Y (2023) Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis. Psychiatr Res 324:115179

Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, Pae CU (2018) Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J 54(2):101–112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR (2007) The STAR* D Project results: a comprehensive review of findings. Curr Psychiatry Rep 9(6):449–459

Article  PubMed  Google Scholar 

Wilkinson ST, Toprak M, Turner MS, Levine SP, Katz RB, Sanacora G (2017) A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders. Am J Psychiatry 174(7):695–696

Article  PubMed  PubMed Central  Google Scholar